Conference
Identification of AML and MDS Patients Who Could Potentially Benefit From Temozolomide Therapy: Proportion of Patients with Low Methyl Guanine Methyltransferase (MGMT) Expression Level.
Authors
Brandwein J; Kassis J; Leber B; Howson-Jan K; Minden MD; Greaves K; Pouliot J-F
Volume
116
Pagination
pp. 1624-1625
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 19, 2010
Name of conference
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
Conference place
Orlando, FL
Conference start date
December 4, 2010
Conference end date
December 7, 2010
Conference proceedings
BLOOD
Issue
21
ISSN
0006-4971